Tesla stock has been on a surge this month and Canaccord analyst George Gianarikas think there's potential for it to go further.

Civitas Resources is unloading risky assets, paying down debt, and buying back ~25% of its market cap. A 6%+ dividend backed by a 29% free cash flow yield makes the payout look rock solid. With shares trading at a 40%+ discount to NAV, CIVI could deliver massive upside.

Cannabis stocks surged after Trump endorsed CBD for senior healthcare, citing its potential to revolutionize treatment and reduce healthcare costs. Shares of TLRY, CGC, CRON, and ACB soared double digits, with related ETFs MSOS and MJ also posting significant gains.

Tech giant Qualcomm Inc. NASDAQ: QCOM has long tested investors' patience. While more well-known peers, such as NVIDIA Corporation NASDAQ: NVDA, have ridden the artificial intelligence (AI) wave to record highs, Qualcomm has remained effectively idle and is currently trading at 2021 levels.

Nvidia has dominated the AI chip race and it is planning to further distance itself from AMD, according to KeyBanc analyst John Vinh.

BioMarin has both a solid revenue portfolio of several products and a promising pipeline. The market's main concern has been TransCon competition; however, the combination of Voxzogo and BMN 333 could effectively fight back. Even if the U.S. government were to regulate prices, it would only affect a small portion of the company, since 64% of its sales originate outside the US.

Platinum (PLTM, PPLT), Palladium (PALL), Lithium (LITP), and Silver (SLVR) ETFs all jumped 10%+ last week despite weak Wall Street.

DURHAM, N.C.--(BUSINESS WIRE)--Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing therapies for high unmet need diseases, today announced a late-breaking poster presentation at the 30th Annual International Congress of the World Muscle Society (WMS) being held October 7-12, 2025, in Vienna, Austria. “We look forward to sharing the latest preclinical data for PBGENE-DMD at the upcoming.

Focal One® Prostate Cancer Awareness Month Campaign Shines Spotlight on Robotic HIFU Treatment Option Focal One Robotic HIFU Patient Story Featured on Health Uncensored with Dr. Drew on Lifetime Network AUSTIN, Texas – September 30, 2025 – EDAP TMS SA (Nasdaq: EDAP), a global leader in robotic energy-based therapies, announced that its non-invasive, nonsurgical treatment option, Focal One Robotic HIFU, was featured on national television on Friday, September 26, reaching millions of viewers nationwide. The segment, which included an interview with a patient treated with Focal One, aired during an episode of Health Uncensored with Dr. Drew on the Lifetime …

MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Aeva® (Nasdaq: AEVA), a leader in next-generation sensing and perception systems, today announced the release of AevaScenes, the industry's first open dataset featuring synchronized, multi-sensor FMCW 4D LiDAR and camera data with object velocity measurements, semantic segmentation, tracking and lane line annotations. Designed to accelerate research in autonomous vehicle perception and expand the adoption of FMCW LiDAR, AevaScenes supports innovation in o.

PALO ALTO, Calif. & NORTH WALES, United Kingdom--(BUSINESS WIRE)--D-Wave Quantum Inc. (NYSE: QBTS) (“D-Wave” or the “Company”), a leader in quantum computing systems, software, and services and the world's first commercial supplier of quantum computers, and North Wales Police (NWP) today announced the completion of a joint proof-of technology project leveraging a hybrid-quantum application to optimize placement of police vehicles for emergency response. The hybrid-quantum technology delivered a.

Opera Neon is the next generation AI browser that takes AI power-users to a whole new level and is able to execute complex tasks or even code on their behalf. OSLO, Norway , Sept.

PROVIDENCE, R.I.--(BUSINESS WIRE)--United Natural Foods, Inc. (NYSE: UNFI) (the “Company” or “UNFI”) today reported financial results for the fourth quarter (13 weeks) and fiscal year (52 weeks) ended August 2, 2025. Fourth Quarter Fiscal 2025 Performance (comparisons to fourth quarter fiscal 2024) Net sales of $7.7 billion; growth of 1.6% on a comparable 13-week basis Net loss of $(87) million; Loss per diluted share (EPS) of $(1.43) Adjusted EBITDA(1) of $116 million Adjusted EPS(1) of $(0.11.

MINNEAPOLIS--(BUSINESS WIRE)--General Mills, Inc. (NYSE: GIS) announced that it will host an Investor Day event at its world headquarters in Minneapolis on Tuesday, Oct. 14, 2025, beginning at 8:30 a.m. CDT. Chairman and Chief Executive Officer Jeff Harmening, Chief Financial Officer Kofi Bruce, and other members of the leadership team will discuss General Mills' strategic priorities and long-term growth plans, with a focus on how the company is driving remarkability across its global brands to.

COCONUT CREEK, Fla., Sept. 30, 2025 (GLOBE NEWSWIRE) -- Willis Lease Finance Corporation (NASDAQ: WLFC) (“WLFC” or the “Company”), the leading lessor of commercial aircraft engines and global provider of aviation services, today announced the appointment of Pascal Picano as Senior Vice President, Aircraft Leasing & Trading, effective immediately.

Platform Empowers Customers to Bring AI From Prototype to Production in Minutes, Not Months Platform Empowers Customers to Bring AI From Prototype to Production in Minutes, Not Months

NEUMÜNSTER, Germany, Sept. 30, 2025 (GLOBE NEWSWIRE) -- Tilray Medical a division of Tilray Brands, Inc. (NASDAQ: TLRY and TSX: TLRY) and a global leader in medicinal cannabis, empowering the therapeutic alliance between patients and healthcare practitioners to make informed individualized health decisions, transforming healthcare today announced the expansion of its Tilray Craft portfolio in Germany with five new cannabis flower products produced in Germany at Tilray's EU‑GMP certified facility in Neumünster as part of the BfArM in‑country cultivation program. The additions reflect Tilray's ongoing commitment to providing physicians and pharmacies with a diverse range of quality, EU‑GMP certified medical …

WAYNE, Pa., Sept. 30, 2025 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel product candidates for immuno-inflammatory diseases, today announced that the Company will host it's 2025 R&D Day in Midtown, New York on Tuesday, October 14, 2025 at 8:00 AM ET to discuss the Company's progress in addressing therapeutic gaps in immuno-inflammatory markets.

Wrap plans to hold a conference call on Wednesday, November 12, 2025 to discuss financial and operational results for the three months ended September 30.

New York, New York, Sept. 30, 2025 (GLOBE NEWSWIRE) -- Oak Hill Advisors (“OHA”) served as Administrative Agent and Lead Left Arranger for a private unitranche financing supporting Francisco Partners' acquisition of Elite. Elite is a leading provider of mission-critical enterprise resource planning (“ERP”) software and integrated payment solutions for law firms globally. OHA is the largest holder of the newly raised debt facility.